Cargando…
CD4(+) cytotoxic T cells: an emerging effector arm of anti-tumor immunity
While CD8(+) cytotoxic T cells have long been considered the primary effector in controlling tumors, the involvement of CD4(+) “helper” T cells in anti-tumor immunity has been underappreciated. The investigations of intra-tumoral T cells, fueled by the recent advances in genomic technologies, have l...
Autores principales: | Jeong, Seongmin, Jang, Nawon, Kim, Minchae, Choi, Il-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068340/ https://www.ncbi.nlm.nih.gov/pubmed/36863358 http://dx.doi.org/10.5483/BMBRep.2023-0014 |
Ejemplares similares
-
Ubiquitin-regulating effector proteins from Legionella
por: Jeong, Minwoo, et al.
Publicado: (2022) -
Cochlin-cleaved LCCL is a dual-armed regulator of the innate immune response in the cochlea during inflammation
por: Rhyu, Hyeong-Jun, et al.
Publicado: (2020) -
Emerging roles of neutrophils in immune homeostasis
por: Lee, Mingyu, et al.
Publicado: (2022) -
A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity
por: Kim, KyeongJin, et al.
Publicado: (2020) -
Emerging roles of PHLPP phosphatases in metabolism
por: Cha, Jong-Ho, et al.
Publicado: (2021)